Immunotherapy Clinical Trials in Shanghai, Shanghai Municipality
11 recruitingShanghai, Shanghai Municipality, China
Showing 1–11 of 11 trials
Recruiting
Phase 2
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
NSCLCImmunotherapyStereotactic Body Radiation Therapy (SBRT)
Fudan University27 enrolled1 locationNCT06738160
Recruiting
Phase 3
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University432 enrolled1 locationNCT06676449
Recruiting
Phase 2
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
Ovarian CancerImmunotherapyPembrolizumab
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT07261683
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Treatment Side EffectsEffects of ImmunotherapyTumor Infiltrating Lymphocyte+2 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098197
Recruiting
Early Phase 1
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
Treatment Side EffectsEffects of ImmunotherapyAdvanced Gynecologic Tumors+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098171
Recruiting
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Advanced Colorectal CarcinomaImmunotherapy
Fudan University208 enrolled10 locationsNCT06521866
Recruiting
Phase 2
A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
RenJi Hospital28 enrolled1 locationNCT06035224
Recruiting
Not Applicable
Toripalimab Combined With Definitive CCRT for LACC Patients
Cervical CancerImmunotherapyChemoradiotherapy
Ruijin Hospital150 enrolled1 locationNCT06256224
Recruiting
Phase 2
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Cervical CancerNeoadjuvant ImmunotherapyFertility-sparing Surgery
Xiaohua Wu30 enrolled1 locationNCT06209294
Recruiting
Phase 2
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaAdjuvant TherapyNeoadjuvant Chemoimmunotherapy
Guo Xufeng73 enrolled1 locationNCT06056336
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital40 enrolled1 locationNCT05740995